Ultragenyx Pharmaceutical Inc. RARE

RARE Company Overview

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapies for serious rare and ultra-rare genetic diseases. The company operates within the biotechnology and pharmaceutical industries, with an emphasis on conditions that have high unmet medical need and limited or no approved treatment options. Its business model centers on developing biologics, gene therapies, and small-molecule products that can achieve meaningful clinical outcomes in narrowly defined patient populations.

Founded in 2010, Ultragenyx has evolved from a development-stage company into a commercial-stage enterprise with multiple approved products and a robust clinical pipeline. The company’s strategic positioning is built on deep expertise in rare disease biology, strong relationships with patient advocacy groups, and an integrated approach spanning research, clinical development, regulatory approval, and global commercialization.